• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病的实验模型:概述

Experimental Models of Cardiovascular Diseases: Overview.

作者信息

Oh Jae Gyun, Ishikawa Kiyotake

机构信息

Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Methods Mol Biol. 2018;1816:3-14. doi: 10.1007/978-1-4939-8597-5_1.

DOI:10.1007/978-1-4939-8597-5_1
PMID:29987807
Abstract

Cardiovascular disease is one of the most common causes of deaths in clinics. Experimental models of cardiovascular diseases are essential to understand disease mechanism, to provide accurate diagnoses, and to develop new therapies. Large numbers of experimental models have been proposed and replicated by many laboratories in the past. Models with significant advantages are chosen and became more popular. Particularly, feasibility, reproducibility, and human disease resemblance are the common key factors for frequently used cardiovascular disease models. In this chapter, we provide a brief overview of these experimental models used for in vitro, in vivo, and in silico studies of cardiovascular diseases.

摘要

心血管疾病是临床上最常见的死亡原因之一。心血管疾病的实验模型对于理解疾病机制、提供准确诊断以及开发新疗法至关重要。过去,许多实验室已经提出并复制了大量的实验模型。具有显著优势的模型被挑选出来并变得更加流行。特别是,可行性、可重复性和与人类疾病的相似性是常用心血管疾病模型的共同关键因素。在本章中,我们简要概述了用于心血管疾病体外、体内和计算机模拟研究的这些实验模型。

相似文献

1
Experimental Models of Cardiovascular Diseases: Overview.心血管疾病的实验模型:概述
Methods Mol Biol. 2018;1816:3-14. doi: 10.1007/978-1-4939-8597-5_1.
2
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚(ADP-核糖)聚合酶(PARP)和 PARP 抑制剂:作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.
3
[Autophagy in the cardiovascular system].[心血管系统中的自噬]
Med Sci (Paris). 2017 Mar;33(3):283-289. doi: 10.1051/medsci/20173303015. Epub 2017 Apr 3.
4
Cardiovascular disease models: A game changing paradigm in drug discovery and screening.心血管疾病模型:药物发现和筛选的变革性范式。
Biomaterials. 2019 Apr;198:3-26. doi: 10.1016/j.biomaterials.2018.09.036. Epub 2018 Oct 1.
5
The updated view on induced pluripotent stem cells for cardiovascular precision medicine.诱导多能干细胞在心血管精准医学中的最新研究进展。
Pflugers Arch. 2021 Jul;473(7):1137-1149. doi: 10.1007/s00424-021-02530-5. Epub 2021 Feb 17.
6
Quest for the cardiovascular holy grail: mammalian myocardial regeneration.对心血管圣杯的探索:哺乳动物心肌再生
Cardiovasc Pathol. 2008 Jan-Feb;17(1):1-5. doi: 10.1016/j.carpath.2007.05.001. Epub 2007 Jul 5.
7
Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats.慢性持续性和间歇性缺氧诱导的全身炎症对大鼠心血管系统的影响。
Sleep Breath. 2015 May;19(2):677-84. doi: 10.1007/s11325-014-1075-9. Epub 2014 Nov 14.
8
Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology.心肌细胞、内皮细胞与心脏成纤维细胞:S100A1在心血管病理生理学中的三重作用
Future Cardiol. 2015 May;11(3):309-21. doi: 10.2217/fca.15.18.
9
Progress in Cardiovascular Imaging.心血管成像进展
JACC Cardiovasc Imaging. 2018 Dec;11(12):1883-1914. doi: 10.1016/j.jcmg.2018.10.014.
10
An Introduction to Computational Modeling of Cardiac Electrophysiology and Arrhythmogenicity.心脏电生理学与致心律失常性的计算建模导论
Methods Mol Biol. 2018;1816:17-35. doi: 10.1007/978-1-4939-8597-5_2.

引用本文的文献

1
FPR2 Agonism Attenuates Restenosis by Mitigating Neointimal Hyperplasia via ELOVL6.FPR2激动作用通过ELOVL6减轻内膜增生从而减轻再狭窄。
FASEB J. 2025 Sep 15;39(17):e71020. doi: 10.1096/fj.202501823R.
2
Guidelines for mitochondrial RNA analysis.线粒体RNA分析指南。
Mol Ther Nucleic Acids. 2024 Jun 26;35(3):102262. doi: 10.1016/j.omtn.2024.102262. eCollection 2024 Sep 10.
3
Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists.心脏疾病的临床前模型:临床科学家的综合概述。
Cardiovasc Eng Technol. 2024 Apr;15(2):232-249. doi: 10.1007/s13239-023-00707-w. Epub 2024 Jan 16.
4
Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.心脏缺血芯片:左西孟旦对缺血性人诱导多能干细胞衍生心肌细胞的抗心律失常作用。
Cells. 2022 Mar 19;11(6):1045. doi: 10.3390/cells11061045.
5
Distinct PRC2 subunits regulate maintenance and establishment of Polycomb repression during differentiation.PRC2 不同亚基在分化过程中调节 Polycomb 抑制的维持和建立。
Mol Cell. 2021 Jun 17;81(12):2625-2639.e5. doi: 10.1016/j.molcel.2021.03.038. Epub 2021 Apr 21.
6
Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned.闭胸猪左前降支缺血再灌注模型的实验参数和梗死面积;经验教训。
BMC Cardiovasc Disord. 2021 Apr 12;21(1):171. doi: 10.1186/s12872-021-01995-7.
7
Alternative strategies in cardiac preclinical research and new clinical trial formats.心脏临床前研究的替代策略和新临床试验模式。
Cardiovasc Res. 2022 Feb 21;118(3):746-762. doi: 10.1093/cvr/cvab075.
8
Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates.胰岛淀粉样多肽沉积激活了非人灵长类动物衰竭心脏中的 HIF1α 和 6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶 3(PFKFB3)信号通路。
Commun Biol. 2021 Feb 12;4(1):188. doi: 10.1038/s42003-021-01676-3.
9
Differentiation Potential of Mesenchymal Stem/Stromal Cells Is Altered by Intrauterine Growth Restriction.间充质干/基质细胞的分化潜能受宫内生长受限的影响而改变。
Front Vet Sci. 2020 Nov 5;7:558905. doi: 10.3389/fvets.2020.558905. eCollection 2020.
10
Quantitative analysis of variability in an integrated model of human ventricular electrophysiology and β-adrenergic signaling.定量分析人类心室电生理学和β-肾上腺素能信号综合模型中的变异性。
J Mol Cell Cardiol. 2020 Jun;143:96-106. doi: 10.1016/j.yjmcc.2020.04.009. Epub 2020 Apr 21.